← Eichor
Condition: Respiratory Syncytial Virus Rsv Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Respiratory Syncytial Virus Rsv Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus )
Phase N/A · 1 location(s) · Tam Anh Research Institute · NCT07239583A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Partici
Phase 2 · 11 location(s) · SynAct Pharma Aps · NCT07633288Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
Phase 3 · 15 location(s) · University of Alabama at Birmingham · NCT05026749Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract In
Phase 3 · 1 location(s) · Kexing Biopharm Co., Ltd. · NCT06363370COVID-19 Impact on RSV Emergency Presentations
Phase N/A · 1 location(s) · University Hospitals, Leicester · NCT04959734Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults
Phase 1 · 5 location(s) · Clover Biopharmaceuticals USA, LLC · NCT06843317Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute
Phase 1/Phase 2 · 3 location(s) · PEACHES BIOTECH · NCT06684379Peginterferon α-2b Injection for the Treatment of Pediatric RSV Bronchiolitis
NA · 3 location(s) · Children's Hospital of Soochow University · NCT06827249A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of
Phase 2 · 83 location(s) · Shionogi · NCT07214571Epidemiological Characteristics and Clinical Burden of RSV Infection in Children Under 24 Months in Ho Chi Minh City (20
Phase N/A · 3 location(s) · Tam Anh Research Institute · NCT07640581Clinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older.
Phase 1/Phase 2 · 1 location(s) · Ab&B Bio-tech Co., Ltd.JS · NCT07582796A Study of BLB-201 RSV Vaccine in Infants and Children
Phase 1/Phase 2 · 16 location(s) · Blue Lake Biotechnology Inc. · NCT05655182A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respirato
Phase 3 · 11 location(s) · University of Witwatersrand, South Africa · NCT06955728Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination
Phase 3 · 1 location(s) · Centre Hospitalier Annecy Genevois · NCT07232706Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
Phase 2 · 3 location(s) · Fred Hutchinson Cancer Center · NCT06817889Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18
Phase 1 · 6 location(s) · Sanofi · NCT07516418A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants
Phase 3 · 18 location(s) · Shanghai Ark Biopharmaceutical Co., Ltd. · NCT06775405Identification and Clinical Validation of Biomarkers Associated With Clinical Severity in Adults Infected With RSV
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06197152Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06881953A Study of Ziresovir (AK0529) in High-risk Adult With Respiratory Syncytial Virus (RSV) Infection.
Phase 2/Phase 3 · 9 location(s) · Shanghai Ark Biopharmaceutical Co., Ltd. · NCT07658534A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 5
Phase 3 · 15 location(s) · GlaxoSmithKline · NCT07220109Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Phase 2 · 67 location(s) · Synairgen Research Ltd. · NCT06999603Assessing Antiviral Treatments in Early Symptomatic RSV
Phase 2 · 2 location(s) · University of Oxford · NCT06488300PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Viru
Phase 2 · 11 location(s) · Pulmotect, Inc. · NCT06665100In-depth Analysis of the Immune Responses in the Upper Respiratory Tract in Older Adults Infected or Colonized With Stre
Phase N/A · 1 location(s) · University Hospital, Geneva · NCT06998251RSV Burden in Outpatient and Hospital Settings
NA · 1 location(s) · Association Clinique Thérapeutique Infantile du val de Marne · NCT04743609Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY®) in Hospitalized Children With RSV
Phase 2 · 8 location(s) · PENTA Foundation · NCT06873633A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children
Phase 3 · 4 location(s) · Simcere Pharmaceutical Co., Ltd · NCT07402512A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age
Phase 2 · 8 location(s) · Enanta Pharmaceuticals, Inc · NCT07482657
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.